Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ABVC ABVC BioPharma, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.08 +0.9% | $15.40 -3.7% |
| StockIQ Score | 48D+ Moderate Risk: High | 35F Weak Risk: High |
| Technical | 65B- | 13F |
| Fundamental | 20F | 35F |
| Growth | 40D | 50C- |
| Fair Value | 50C- | 38F |
| News | 80A- | 50C- |
| Quality | 47D+ | 50C- |
| Risk | 32F | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
ABVC BioPharma scores higher in technical (50 vs. 18) and valuation (50 vs. 38) metrics, showing stronger market trends and pricing relative to peers. However, AAPG leads in growth (50 vs. 40), indicating faster expansion potential. Both carry a "WEAK" rating, but ABVC’s higher technical and valuation scores make it appear more stable in those areas.
